Innoviva Stock Just This: Why a Fund Bought $2.5M More
A boutique fund recently boosted its Innoviva stake by $2.5 million, raising questions about the stock's modest 10% g...
We review which stablecoins fall under regulatory scrutiny, the regimes that apply, and practical implications for users and providers alike.
19,598 articlesA boutique fund recently boosted its Innoviva stake by $2.5 million, raising questions about the stock's modest 10% g...
Even with a raised Social Security check, rising prices can erode your buying power. Learn how inflation quietly eati...
Want income that compounds over time? These high-yield energy stocks offer reliable payouts and growth potential. Lea...
As inflation concerns linger, institutional moves into commodity-focused ETFs attract attention. This article breaks ...
ICE launches an Encompass-integrated Fraud Monitor, centralizing fraud risk signals and property data. Early pilots i...
NOWPayments launches a zero-fee, instant crypto payout platform built for high-volume partners, delivering 1-second s...
When cultural moments go big, your wallet pays attention. This article breaks down how Pink and Queen Latifah are exp...
State investigators are scrutinizing FIFA ticketing as dynamic pricing drives eye-popping costs and questions about s...
Broadcom shares rose in early trading after Alphabet unveiled an up-to-$80 billion plan to expand AI infrastructure, ...
Dogecoin trades around $0.096 after a weekly drop, with analysts pointing to a TD Sequential buy signal and key suppo...
Two pharma giants are wighting for a leadership position in immunology. This piece explains why Johnson Johnson hopes...
Ford faced headwinds in its EV push, but a bold pivot could unlock durable value. Explore the battery storage strateg...